IAS 2021 Scientific Programme Committee

Adeeba Kamarulzaman International Co-Chair

IAS 2021 International Co-Chair (IAS President)

Adeeba Kamarulzaman, Malaysia 

University of Malaya 

Professor Adeeba Kamarulzaman is the Dean of the Faculty of Medicine, University of Malaya, and chairs the Malaysian AIDS Foundation. In April 2015, she was awarded an Honorary Doctor of Laws from her alma mater, Monash University, for her outstanding achievements in the field of infectious diseases and as a health advocate. In addition to her clinical and academic commitments, Dr Kamarulzaman has been actively involved in the community response to HIV and AIDS in Malaysia. As convenor of the Malaysian Harm Reduction Working Group of the Malaysian AIDS Council, she led the advocacy for the implementation of harm reduction to tackle the problem of HIV among people who inject drugs in Malaysia. In 2008, she established the Centre of Excellence for Research in AIDS at the University of Malaya. Dr Kamarulzaman is a committee member of several regional and international organizations, including TREAT Asia and the International Society of Infectious Diseases, and has served as Co-Chair of the World Health Organization Strategic and Technical Advisory Group on HIV.   

IAS 2021 Local Co-Chair

Hendrik Streeck, Germany 

University of Bonn 

Professor Hendrik Streeck is the Director of the Institute of Virology and Professor of HIV Research at the University of Bonn, Germany. He completed his medical training in Berlin in 2006 and received his PhD from Friedrich-Wilhelm University in Bonn in 2007. After completing his postdoctoral fellowship at the Partners AIDS Research Center, he was Assistant Professor at the Ragon Institute of MGH, MIT and Harvard and assistant immunologist at the Massachusetts General Hospital. In 2012, he was recruited as the Chief of the Cellular Immunology Section of the U.S. Military HIV Research Program and adjunct Assistant Professor of Emerging Infectious Diseases at the Uniformed Services University of the Health Sciences. In March 2015, he took the chair of the Institute for HIV Research, but remains visiting scientist at the Military HIV Research Program on HIV vaccine and cure research. Currently, he leads the largest systematic study to understand the feasibility of conducting a Phase 3 HIV vaccine trial in Europe and to understand the epidemic of sexually transmitted infections. As a result of the study, the European HIV & STI prevention network was established in January 2019. 

IAS President-Elect

Sharon Lewin, Australia 

Peter Doherty Institute for Infection and Immunity 

Professor Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne, Australia, and Royal Melbourne Hospital. She is Professor of Infectious Diseases at the University of Melbourne, a consultant physician at the Alfred Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow in Melbourne. She is an infectious diseases physician and basic scientist. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. Professor Lewin is the Co-Chair of the Scientific Advisory Board for the Towards an HIV Cure Initiative led by IAS – the International AIDS Society. She is also a member of the IAS Governing Council, representing the Asia Pacific region.

IAS Regional Representative

Cristina Mussini, Italy 

University of Modena and Reggio Emilia 

Dr Cristina Mussini has been Professor of Infectious Diseases at the University of Modena and Reggio Emilia since 2011. She is also the Director of the Clinic of Infectious Diseases, Azienda Ospedaliero-Universitaria Policlinico, in Modena, Italy. She received her degree in medicine and surgery at the University of Modena in 1987 and completed a specialization in infectious diseases in 1990. Dr Mussini has published more than 200 papers on index journals for a total of above 900, H-index 55 (Google Scholar). From 2009 to 2016, she was a member of the National AIDS Committee of the Italian Ministry of Health. Since 2000, she has been a member of the Governing Board of the European AIDS Clinical Society (EACS). She is a member of the Scientific Committees for the EACS and Glasgow European Conferences and a member of the Scientific Committee of the Icona Cohort Study. She is Chair of the ESGIE, ESCMID study group for infections in the elderly. She has taught all over the world, including Turkey, Russia, Iran and Kenya. She organized the first EACS standard of care meeting in Rome to bring NGOs, political stakeholders and clinicians together to discuss HIV in Europe. 

 

 

International Community Representative

Joe Wong, Malaysia 

Asia Pacific Transgender Network 

Joe Wong is a transmasculine advocate and was born in Singapore. As the Executive Director of the Asia Pacific Transgender Network (APTN), he provides overall leadership and management. He was actively leading in the transgender HIV response well before he assumed his role at APTN in 2010. Joe was the driving force behind the Asia Pacific Trans Health Blueprint, a regional contextual map outlining key challenges, gaps and interventions for transgender people. He has written on and implemented best practices and continues to prove that there can be no real response to the advancement of trans sexual health and human rights without the presence, voices and contributions of transgender people. 

 

Local/Regional Community Representative

Ricardo Fernandes, Portugal 

Grupo de Ativistas em Tratamentos 

Ricardo Fernandes has worked for several Portuguese NGOs in the field of HIV since 2000, mainly in project and services coordination. He has a degree in modern languages and literature from the University of Lisbon. He is the Executive Director of the Portuguese Group of Activists for HIV/AIDS Treatment (GAT) and is currently the Chair of the European AIDS Treatment Group (EATG). He is also a co-organizer of several Portuguese conferences and co-author of studies and articles mainly on stigma, diagnosis and late presentation for HIV care. 

Track A: Basic science

Reena Rajasuriar, Malaysia

University of Malaya

Reena Rajasuriar is an Associate Professor in the Department of Medicine, University of Malaya, and an adjunct Research Fellow at the Peter Doherty Institute for Infection and Immunity, Melbourne University, Australia. Dr Rajasuriar graduated with her Bachelor of Pharmacy (Hons) and Masters in Clinical Pharmacy from the University of Science, Malaysia. She was awarded her PhD in immunology by Monash University, Australia. She coordinates the translational research programme in HIV Immunology and Ageing at the Centre of Excellence for Research in AIDS (CERiA) and heads the Immunotherapeutics Laboratory at the University of Malaya. Her research focuses on understanding the immunopathogenesis of aging in people living with HIV and other disease models of accelerated aging, specifically in cancer survivors.

TBA

Track B: Clinical science

Esper G Kallas, Brazil

University of São Paulo

Esper G Kallas, MD, PhD, is an Infectious Diseases Specialist and Full Professor of Medicine at the Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo, Brazil, where he directs the HIV/AIDS Outpatient Clinic. He coordinates a clinical site for HIV treatment and prevention clinical trials. Dr Kallas also conducts projects on HIV immunopathogenesis, including senescence, immune activation, cure approaches, novel PrEP strategies and candidate HIV vaccine clinical trials.

Georg Behrens, Germany

Hannover Medical School

Georg Behrens is Professor of T Cell Immunology at Hannover Medical School, Germany. He is a specialist in internal medicine and infectious disease and was trained at the Immunology Division at the Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia. He is the principal investigator of several national and international studies in HIV medicine and was President of the German AIDS Society from 2011 to 2019. Currently, he is an EACS Governing Board member and Chair of the EACS Treatment Guidelines. He is a NEAT-ID steering committee member, member of the German Center for Infection Research (DZIF) and Chair of the MD/PhD Programme in Molecular Medicine.

Track C: Prevention science

Nelly Mugo, Kenya

Kenya Medical Research Institute

Nelly Mugo has 27 years’ experience as a reproductive health specialist, from rural district facilities to Kenya’s national teaching hospital. Her work has largely shifted to research, with a focus on reproductive health and HIV prevention clinical research. Ten years ago, she began working in HIV prevention, with a collaboration with the International Clinical Research Center, University of Washington: she was a Regional Director for the HSV/HIV transmission clinical trial with 14 sites in seven countries in East and southern Africa. Thereafter, she initiated a clinical trial site in Thika, Kenya, part of two landmark HIV prevention trials, the HSV/HIV Transmission Study and the Partners PrEP Study (both with serodiscordant couples), as well as several observational related studies. Currently, she leads a research team in Thika and works as a senior research scientist at the Kenya Medical Research Institute (KEMRI), heading the sexual reproductive and adolescent child health research programme.

Frits van Griensven, Thailand

Thai Red Cross Society

Frits van Griensven is an expert consultant in HIV epidemiology and prevention with the Thai Red Cross AIDS Research Centre in Bangkok, Thailand, and an adjunct faculty member in the Department of Epidemiology and Biostatistics of the University of California, San Francisco, USA. He started his career in HIV and AIDS in Amsterdam, the Netherlands in 1983; he was one of the first to describe the emerging HIV epidemic in men who have sex with men in western Europe. He received his PhD in medical science from the University of Amsterdam in 1989 and completed his postdoctoral studies in epidemiology at the School of Public Health of the University of California, Berkeley. In 1993, he joined the AIDS Programme of the European Commission to assist with its activities in Asia. In 1995, he became Professor in the Social Epidemiology of HIV/AIDS at the University of Utrecht. In 1998, he took a position with the US Centers for Disease Control and Prevention at its field station in Bangkok. Fritz van Griensven is widely credited for his role in uncovering the HIV epidemic among men who have sex with men and transgender women in South-East Asia and is well known for his innovative models of clinical service delivery for these populations. In July 2018, he was knighted in the Order of the Lion of the Netherlands. He has published more than 250 scientific papers on HIV and AIDS.

Track D: Social, behavioural and implementation science

Frederick L Altice, United States

Yale University

Rick Altice is a Professor of Medicine and Public Health at Yale University and leads Yale’s Center for Clinical and Community Research. His clinical care, research and advocacy work has focused on HIV prevention and treatment issues in key populations, including people who inject drugs, men who have sex with men, transgender women, sex workers and prisoners. His interests concentrate on the intersection of HIV and substance use disorders and centre on global health with concentrated activities in eastern Europe, Central Asia, South-East Asia, Peru and the United States. Much of his research and care focuses on implementation science to bring evidence-based practices to diverse cultural contexts.

Till Bärnighausen

Till Bärnighausen, Germany

University of Heidelberg

Till Bärnighausen is the Director of the Heidelberg Institute of Global Health (HIGH), a research centre in the Medical Faculty and University Hospital of the University of Heidelberg, Germany’s oldest university (1386). He is also the Alexander von Humboldt University Professor at the University of Heidelberg, Adjunct Professor of Global Health at the Department of Global Health and Population at Harvard T.H. Chan School of Public Health and Senior Faculty at the Wellcome Trust’s Africa Health Research Institute (AHRI) in South Africa. Professor Till’s research focuses on designing novel interventions for population health and establishing the causal impact of interventions on population health, social and economic outcomes. In particular, he works on large-scale population health interventions for chronic diseases, such as HIV, diabetes, hypertension and depression, and maternal and child health.